(CSNDX) iShares NASDAQ 100 USD - Ratings and Ratios

Exchange: SW • Country: Switzerland • Currency: USD • Type: Etf • ISIN: IE00B53SZB19

US, Large-Cap, Growth, Stocks

Description: CSNDX iShares NASDAQ 100 USD

The iShares NASDAQ100 UCITS ETF USD (Acc) (SW:CSNDX) is a US Large-Cap Growth Equity ETF listed in Switzerland, tracking the Morningstar US LM Brd Growth NR USD Index. As a fund that focuses on large-cap growth stocks in the US market, it is likely to be heavily weighted in technology and other growth-oriented sectors.

Given its underlying index, the ETF is expected to have a significant allocation to the NASDAQ-100 Index constituents, which are predominantly US technology and growth companies. This implies that the funds performance will be closely tied to the fortunes of these companies, making it a potentially attractive option for investors seeking exposure to the US technology and growth sectors.

Analyzing the , we observe that the ETFs last price is 1253.00, with a 20-day SMA of 1213.90, indicating a recent uptrend. The 50-day SMA (1138.70) and 200-day SMA (1167.29) also suggest a longer-term bullish trend, as the short-term SMAs are above the longer-term SMAs. The ATR of 18.93 (1.51%) indicates moderate volatility. Using these technical indicators, we can forecast that the ETF is likely to continue its upward trend in the short term, potentially reaching the 52-week high of 1267.80.

Combining the technical analysis with the , we note that the AUM of 15910.04M USD indicates a substantial investor base and liquidity. This, coupled with the ETFs focus on large-cap growth stocks, suggests that it is a popular and relatively stable investment option. Using both technical and fundamental data, our forecast suggests that the ETF will continue to perform well in the short term, driven by the strength of its underlying constituents and the overall trend in the US technology and growth sectors.

Based on the analysis, a potential trading strategy could be to buy the ETF on dips towards the 20-day SMA (1213.90) and hold it with a target price of 1300, anticipating further growth driven by the underlying trend and investor demand. However, a stop-loss should be set below the 50-day SMA (1138.70) to limit potential losses in case of a trend reversal.

Additional Sources for CSNDX ETF

Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle

CSNDX ETF Overview

Market Cap in USD 15,910m
Category US Large-Cap Growth Equity
TER 0.30%
IPO / Inception 2010-01-26

CSNDX ETF Ratings

Growth Rating 68.3
Fundamental -
Dividend Rating 0.0
Rel. Strength 0.26
Analysts -
Fair Price Momentum 1223.24 USD
Fair Price DCF -

CSNDX Dividends

Currently no dividends paid

CSNDX Growth Ratios

Growth Correlation 3m 95%
Growth Correlation 12m 43.2%
Growth Correlation 5y 74.9%
CAGR 5y 16.91%
CAGR/Max DD 5y 0.48
Sharpe Ratio 12m 2.21
Alpha 0.11
Beta 1.061
Volatility 16.11%
Current Volume 2.4k
Average Volume 20d 2.8k
What is the price of CSNDX shares?
As of July 03, 2025, the stock is trading at USD 1296.20 with a total of 2,389 shares traded.
Over the past week, the price has changed by +1.82%, over one month by +6.14%, over three months by +16.00% and over the past year by +14.04%.
Is iShares NASDAQ 100 USD a good stock to buy?
Yes. Based on ValueRay's Analyses, iShares NASDAQ 100 USD (SW:CSNDX) is currently (July 2025) a good stock to buy. It has a ValueRay Growth Rating of 68.34 and therefor a clear technical positive rating according to historical growth.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of CSNDX is around 1223.24 USD . This means that CSNDX is currently overvalued and has a potential downside of -5.63%.
Is CSNDX a buy, sell or hold?
iShares NASDAQ 100 USD has no consensus analysts rating.
What are the forecasts for CSNDX share price target?
According to our own proprietary Forecast Model, CSNDX iShares NASDAQ 100 USD will be worth about 1441.6 in July 2026. The stock is currently trading at 1296.20. This means that the stock has a potential upside of +11.22%.
Issuer Target Up/Down from current
Wallstreet Target Price - -
Analysts Target Price - -
ValueRay Target Price 1441.6 11.2%